Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Hansteen Holdings PLC

6 Jan 2020 11:28

RNS Number : 8621Y
Hansteen Holdings plc
06 January 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Hansteen Holdings PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Hansteen Holdings PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

3rd January 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Shares held by the directors of Hansteen Holdings PLC as well as related parties

 

Beneficial owner/controller

Number of ordinary shares of 10p each in the offeree interested in

Percentage of total issued share capital (%) (excluding shares under option) of the offeree

Mr Morgan L Jones

11,552,789

2.704%

Mrs Mary C Jones*

3,820

0.001%

Mr Russel T Jones*

319

0.000%

Mr Ian R Watson

11,552,789

2.704%

Ms Bronte Watson*

10,642

0.002%

Mr Alexander & Mrs Jean Watson*

764

0.000%

Mr Christopher M Watson*

382

0.000%

Mr Richard Lowes

257,659

0.060%

Mrs Bernadette L Lowes*

403,430

0.094%

Mr Melvyn Egglenton

21,436

0.005%

Mrs Wendy Egglenton*

81,420

0.019%

Mr Samuel Watson*

22,008

0.005%

Mr Joseph Watson*

22,008

0.005%

Mr James Watson*

22,008

0.005%

Mr Matthew Watson*

4,803

0.001%

Mr David Rough

32,001

0.007%

Mr Jim Clarke

30,906

0.007%

Total

24,019,184

5.621%

* Family member of Director

 

b) Options held by the directors of Hansteen Holdings PLC

 

Name

Plan

Date of grant

Earliest

Exercise date1

Expiry date

Option price

Maximum number of shares subject to the award2

Mr Morgan L Jones

PSP5

16/03/2015

16/03/2020 (All)

16/03/2025

0p

123,464

Mr Morgan L Jones

PSP6

14/04/2016

14/04/2020 (1/2)

14/04/2021 (1/2)

14/04/2026

0p

262,463

Mr Ian R Watson

PSP5

16/03/2015

16/03/2020 (All)

16/03/2025

0p

123,464

Mr Ian R Watson

PSP6

14/04/2016

14/04/2020 (1/2)

14/04/2021 (1/2)

14/04/2026

0p

262,463

Mr Richard Lowes

PSP5

16/03/2015

16/03/2020 (All)

16/03/2025

0p

79,370

Mr Richard Lowes

PSP6

14/04/2016

14/04/2020 (1/2)

14/04/2021 (1/2)

14/04/2026

0p

184,349

Mr Richard Lowes

PSP7

04/05/2017

04/05/2020 (1/3)

04/05/2021 (1/3)

04/05/2022 (1/3)

04/05/2027

0p

337,383

Mr Richard Lowes

PSP8

20/04/2018

20/04/2021 (1/3)

20/05/2022 (1/3)

20/05/2023 (1/3)

20/04/2028

0p

335,186

Mr Richard Lowes

PSP9

25/04/2019

25/04/2022 (1/3)

25/04/2023 (1/3)

25/04/2024 (1/3)

25/04/2029

0p

351,122

Total

2,059,264

 

1 Awards are subject to three-year performance conditions and exercisable in three equal instalments commencing with the date 3 years after the date of grant.

2 Upon any exercise of options under the PSP, the Directors exercising such options will also receive additional Ordinary shares ("Dividend Shares") with an aggregate value equal to the dividends that would otherwise have been payable on the ordinary shares in respect of which such options are exercised from the date of grant of such options to the date of exercise. The precise number of such Dividend Shares will be dependent on the date of exercise, and in the case of PSP 6,7,8 and 9, will also be subject to the achievement of the performance conditions. Assuming an exercise date of 4 February 2020 and 100% achievement of performance conditions the maximum number of Dividend Shares attributable to the 2,059,264 share awards detailed above is 256,658 shares.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

6th January 2020

Contact name:

Richard Lowes

Finance Director

 

Telephone number:

020 74087014

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEKKABBDBKDPDK
Date   Source Headline
23rd Feb 20177:01 amRNSForm 8 (OPD)
23rd Feb 20177:00 amRNSForm 8 (DD)
22nd Feb 20172:39 pmRNSForm 8 (DD) - Amendment
22nd Feb 20172:35 pmRNSForm 8 (DD) - Amendment
22nd Feb 20177:01 amRNSForm 8 (DD)
22nd Feb 20177:00 amRNSPublication of Offer Document
21st Feb 201712:00 pmRNSForm 8 (DD)
20th Feb 20173:19 pmRNSAcquisition of IMPT Shares
20th Feb 201712:00 pmRNSForm 8 (DD)
20th Feb 20177:00 amRNSOffer for Industrial Multi Property Trust
17th Feb 20177:00 amRNSRecommended Cash Offer for IMPT
18th Jan 20178:00 amRNSNotice of Results
4th Jan 20171:20 pmRNSHolding(s) in Company
4th Jan 20171:15 pmRNSHolding(s) in Company
23rd Dec 20165:40 pmRNSHolding(s) in Company
5th Dec 20167:00 amRNSPortfolio Update
21st Nov 20165:02 pmRNSHolding(s) in Company
21st Nov 20163:28 pmRNSPDMR Shareholding
7th Nov 20165:18 pmRNSHolding(s) in Company
21st Oct 20163:16 pmRNSHolding(s) in Company
20th Oct 20164:51 pmRNSHolding(s) in Company
18th Oct 20161:54 pmRNSHolding(s) in Company
16th Sep 201610:29 amRNSHolding(s) in Company
13th Sep 20163:20 pmRNSHolding(s) in Company
12th Sep 201612:53 pmRNSHolding(s) in Company
8th Sep 20163:25 pmRNSHolding(s) in Company
8th Sep 20162:09 pmRNSHolding(s) in Company
6th Sep 20164:12 pmRNSTransaction in Own Shares
1st Sep 20161:04 pmRNSHolding(s) in Company
23rd Aug 20168:00 amRNSCorporate Governance
23rd Aug 20167:00 amRNSHalf-year Report
26th Jul 20167:00 amRNSHansteen acquires £39.5 million of AIF units
18th Jul 20167:00 amRNSHansteen acquires Ashtenne Industrial Fund
13th Jul 201611:01 amRNSHolding(s) in Company
13th Jul 20168:00 amRNSNotice of Results
13th Jul 20167:00 amRNSRefinancing of Netherlands portfolio
30th Jun 20164:13 pmRNSHolding(s) in Company
30th Jun 201610:45 amRNSTotal Voting Rights
15th Jun 20163:59 pmRNSNotification of PDMR
15th Jun 20163:41 pmRNSTransaction in Own Shares
6th Jun 20164:50 pmRNSResult of AGM
6th Jun 201610:23 amRNSBOARD CHANGES
2nd Jun 20165:22 pmRNSHolding(s) in Company
5th May 201612:08 pmRNSNotice of adjustment to bond conversion price
28th Apr 20162:43 pmRNSNotice of AGM and publication of Annual Report
25th Apr 201612:07 pmRNSHansteen acquires £5.6 million of AIF units
21st Apr 20165:17 pmRNSDirector/PDMR Shareholding
20th Apr 201612:58 pmRNSDirector/PDMR Shareholding
7th Apr 20165:09 pmRNSTransaction in Own Shares
7th Apr 20165:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.